Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, 13620, Gyeonggi-do, Korea.
Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1893-1900. doi: 10.1007/s00417-023-05984-8. Epub 2023 Feb 7.
This study aims to investigate the association between incident central retinal artery occlusion (CRAO) and the subsequent development of cancer.
We included incident CRAO patients from the 2002-2013 National Health Insurance Service database in South Korea. For the patient cohort, we included patients diagnosed with CRAO from the database, and excluded patients having CRAO or any cancer history during the first 2-year washout period (2002-2003). Then, we defined their 1:4 propensity-score matched non-CRAO subjects as controls, all of whom also had no history of cancer during the washout period. Time-varying covariate Cox regression models were conducted to determine the association of CRAO with cancer. Kaplan-Meier curves with log-rank test were also analyzed.
A total of 9712 patients with CRAO and 38,848 controls were included in the study. CRAO was associated with an increased risk of subsequent cancer (hazard ratio = 1.27; 95% confidence interval, 1.19-1.35). The incidence rate of overall cancer during the study period was 29.12 per 1000 person-years in the CRAO group and 22.77 per 1000 person-years in the control group. Incidence probability of overall cancer was significantly higher among CRAO patients than controls (P < 0.001, log-rank test).
The risk of cancer occurrence was increased in patients with CRAO. The results supported that CRAO could be attributed to one of the consequences of arterial thrombosis in cancer patients.
本研究旨在探讨中央视网膜动脉阻塞(CRAO)的发病与随后癌症发生之间的关系。
我们纳入了韩国 2002 年至 2013 年国家健康保险服务数据库中发生的 CRAO 患者。对于患者队列,我们纳入了数据库中诊断为 CRAO 的患者,并排除了在 2 年洗脱期(2002-2003 年)内患有 CRAO 或任何癌症病史的患者。然后,我们将他们的 1:4 倾向评分匹配的非 CRAO 患者定义为对照组,这些患者在洗脱期内也没有癌症病史。采用时变协变量 Cox 回归模型来确定 CRAO 与癌症的关系。还进行了 Kaplan-Meier 曲线和对数秩检验。
共纳入 9712 例 CRAO 患者和 38848 例对照者。CRAO 与随后癌症的风险增加相关(风险比=1.27;95%置信区间,1.19-1.35)。在研究期间,CRAO 组的总体癌症发生率为 29.12/1000 人年,对照组为 22.77/1000 人年。CRAO 患者的总体癌症发生率明显高于对照组(P<0.001,对数秩检验)。
CRAO 患者发生癌症的风险增加。结果支持 CRAO 可能是癌症患者动脉血栓形成的后果之一。